11 March 2016
Company Announcements Office Australian Securities Exchange 10th Floor
20 Bond Street
SYDNEY NSW 2000
Dear Sir
ResApp Health Limited (ASX: RAP) ("Company") refers to the ASX announcement released on 22 February 2016 regarding the appointment of Brian Leedman as Executive Director of Corporate Affairs.
Pursuant to the ASX Listing Rule 3.16.4 the Company confirms the material terms of the Consultancy Agreement ("Agreement") between the Company and Mr Leedman as set out in Annexure A.
Yours faithfully
Level 24, 44 St Georges Tce, Perth WA 6000
T +61 8 6211 5099 E info@resapphealth.com.au W www.resapphealth.com.au
The material terms of the Consultancy Agreement ("Agreement") between the Company and Mr Leedman are set out below.
The Agreement is for a period of 18 months, subject to early termination and renewal in accordance with the Agreement ("Term"). The total remuneration payable to Mr Leedman is $75,000 per annum.
In addition to his duties as a director of the Company, Mr Leedman will be responsible for managing the Company's corporate affairs in respect of investors, ASX announcements, conferences and media.
During the Term, the Agreement may be terminated with immediate effect by written notice for specified serious breaches. Otherwise, the Agreement may be terminated by either Party at any time without cause by giving not less than 3 months' notice in writing.
The Agreement contains additional provisions considered standard for agreements of this nature including confidentiality, intellectual property and conflicts of interest.
ResApp Health Limited issued this content on 11 March 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 14 March 2016 01:10:12 UTC
Original Document: http://www.resapphealth.com.au/wp-content/uploads/2016/03/1535354.pdf